0000000000761823

AUTHOR

Ahmed A

showing 2 related works from this author

Association between night-time surgery and occurrence of intraoperative adverse events and postoperative pulmonary complications

2019

WOS: 000458513600019

Lung DiseasesPostoperative Complications/epidemiologyMaleInternationalityIntraoperative Complicationmedicine.medical_treatmentSettore MED/41 - Anestesiologia[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractLung DiseaseCohort StudiesBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Anesteziologija i reanimatologija.0302 clinical medicine030202 anesthesiologyRisk Factorspatient safetyMedicineGeneral anaesthesiapostoperative complicationProspective Studiesintraoperative complicationsStatistics & numerical dataProspective cohort studyIncidence (epidemiology)Incidencegeneral anaesthesia intraoperative complications patient safety postoperative complications pulmonaryMiddle AgedOperative3. Good healthSurgical Procedures OperativeFemalegeneral anaesthesia ; intraoperative complications ; patient safety ; postoperative complications ; pulmonaryCohort studyHumanAdultmedicine.medical_specialtypulmonaryLung Diseases/epidemiology[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/SurgeryNO03 medical and health sciencesgeneral anaesthesia; intraoperative complications; patient safety; postoperative complications; pulmonary;Intraoperative Complications/epidemiologyAfter-Hours Carepostoperative complicationsHumansgeneral anaesthesiaMED/41 - ANESTESIOLOGIAAdverse effectAgedMechanical ventilationSurgical Proceduresbusiness.industryRisk FactorBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Anesthesiology and Reanimatology.intraoperative complicationSurgeryAfter-Hours Care/statistics & numerical datageneral anaesthesia; intraoperative complications; patient safety; postoperative complications; pulmonary; Anesthesiology and Pain MedicineClinical trialMESH: After-hours Care / statistics & numerical data; Lung diseases / epidemiology; Surgical procedures operativeProspective StudieAnesthesiology and Pain Medicine[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCohort Studiebusiness
researchProduct

Liraglutide and Renal Outcomes in Type 2 Diabetes.

2017

BACKGROUND: In a randomized, controlled trial that compared liraglutide, a glucagon-like peptide 1 analogue, with placebo in patients with type 2 diabetes and high cardiovascular risk who were receiving usual care, we found that liraglutide resulted in lower risks of the primary end point (nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) and death. However, the long-term effects of liraglutide on renal outcomes in patients with type 2 diabetes are unknown. METHODS: We report the prespecified secondary renal outcomes of that randomized, controlled trial in which patients were assigned to receive liraglutide or placebo. The secondary renal outcome was a co…

MaleSettore MED/09 - Medicina InternaAcute Kidney Injury; Aged; Albuminuria; Creatinine; Diabetes Mellitus Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Intention to Treat Analysis; Kidney Failure Chronic; Liraglutide; Male; Middle AgedType 2 diabetes030204 cardiovascular system & hematologyurologic and male genital diseasesGLOMERULAR-FILTRATION-RATEKIDNEY-FUNCTIONDISEASElaw.inventionKidney Failurechemistry.chemical_compound0302 clinical medicineRandomized controlled trialGlucagon-Like Peptide 1lawMedicineDiabetic NephropathiesHypoglycemic Agents.Settore MED/49 - Scienze Tecniche Dietetiche ApplicateChronicRISKKidneyAcute kidney injury11 Medical And Health SciencesGeneral MedicineAcute Kidney InjuryMiddle AgedIntention to Treat Analysismedicine.anatomical_structureCreatinineTRIALFemaleliraglutide randomized controlled trial type 2 diabetes renal outcomesLife Sciences & BiomedicineType 2Glomerular Filtration Ratemedicine.drugmedicine.medical_specialtyRenal function030209 endocrinology & metabolismCARDIOVASCULAR OUTCOMESFollow-Up Studie03 medical and health sciencesMedicine General & InternalDouble-Blind MethodGeneral & Internal MedicineDiabetes mellitusInternal medicineDiabetes MellitusAlbuminuriaHumansHypoglycemic AgentsIntensive care medicineAgedCreatinineScience & Technologybusiness.industryLiraglutideMORTALITYLiraglutidemedicine.diseaseINTENSIVE GLUCOSE CONTROLINDIVIDUALSDiabetes Mellitus Type 2chemistryDiabetic NephropathieKidney Failure ChronicLEADER Steering Committee and InvestigatorsbusinessFollow-Up Studies
researchProduct